Biologics and oral small-molecule inhibitors for treatment of pediatric atopic dermatitis: Opportunities and challenges

被引：4
|
作者：
Zhao, Anqi [1 ,2 ,3 ]
Pan, Chaolan [1 ,2 ]
Li, Ming [3 ,4 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Dermatol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Inst Dermatol, Shanghai, Peoples R China
[3] Fudan Univ, Dept Dermatol, Childrens Hosp, Shanghai, Peoples R China
[4] Fudan Univ, Childrens Hosp, Dept Dermatol, Shanghai 200092, Peoples R China
来源：
PEDIATRIC INVESTIGATION | 2023年 / 7卷 / 03期
关键词：
Atopic dermatitis; Biologics; Clinical trials; Dupilumab; Pediatrics; Small-molecule inhibitors; DOUBLE-BLIND; PLACEBO; ADOLESCENTS; ANTIBODY; ADULTS; UPADACITINIB; DUPILUMAB; EFFICACY; CHILDREN; SAFETY;
D O I：
10.1002/ped4.12400
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Atopic dermatitis (AD) is a complex disease characterized by recurrent eczematous lesions and refractory pruritus that drastically impairs quality of life. Due to the chronic and relapsing course, patients are easily trapped in the debilitating condition. Classical therapies show limitations, especially for patients with moderate-to-severe phenotypes. Advanced new insights in targeted therapies exhibit great application prospects which were reinforced by the more profound understanding of the disease pathogenesis. However, the sustained efficiency, biosafety, and long-term benefits still remain in further exploration. This review summarizes recent clinical studies on oral small-molecule inhibitors and biological agents for pediatric AD patients, which provides the latest frontiers to clinicians. *image
引用
收藏
页码：177 / 190
页数：14
相关论文
共 50 条
  • [1] Biologics and oral small-molecule inhibitors for treatment of pediatric atopic dermatitis: Opportunities and challenges
    Zhao Anqi
    Pan Chaolan
    Li Ming
    儿科学研究（英文）, 2023, 07 (03)
  • [2] Emerging small-molecule compounds for treatment of atopic dermatitis: a review
    Vavrova, Katerina
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (01) : 21 - 34
  • [3] Modern therapies in atopic dermatitis: biologics and small molecule drugs
    Worm, Margitta
    Francuzik, Wojciech
    Kraft, Magdalena
    Alexiou, Aikaterina
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (10): : 1085 - 1092
  • [4] Treatment of atopic dermatitis with biologics and Janus kinase inhibitors
    Thyssen, Jacob P.
    Thomsen, Simon F.
    LANCET, 2021, 397 (10290): : 2126 - 2128
  • [5] Current and emerging biologics for the treatment of pediatric atopic dermatitis
    Ghamrawi, Rima
    Bell, Katheryn A.
    Balogh, Esther A.
    Strowd, Lindsay C.
    Feldman, Steven R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (12) : 1435 - 1445
  • [6] Prediction of Apparent Oral Clearance of Small-Molecule Inhibitors in Pediatric Patients
    Kimura, Yoshihiko
    Chisaki, Yugo
    Saki, Tomohiko
    Matsumura, Chikako
    Motohashi, Hideyuki
    Onoue, Masahide
    Yano, Yoshitaka
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (03) : 949 - 956
  • [7] Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors
    Chan, Jonathan
    Gladman, Dafna
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 415 - 426
  • [8] Biologics in Pediatric Psoriasis and Atopic Dermatitis: Revolutionizing the Treatment Landscape
    Scott, Jennifer B.
    Paller, Amy S.
    CUTIS, 2020, 106 (05): : 224 - +
  • [9] Treatment of Hailey-Hailey disease with biologics and small-molecule inhibitors: a systematic review
    Liu, Wei
    Xue, Xiao
    Li, Shanshan
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 50 (01) : 38 - 45
  • [10] Oral Janus Kinase Inhibitors in Pediatric Atopic Dermatitis
    Navarrete-Rodriguez, Elsy M.
    Larenas-Linnemann, Desiree
    de la Cruz, Helena Vidaurri
    Luna-Pech, Jorge A.
    Sangines, Esther Guevara
    CURRENT ALLERGY AND ASTHMA REPORTS, 2024, 24 (09) : 485 - 496
12345